$460M 3% convertible notes due 2029
Company: Core Scientific
The claim, verbatim
Company issued $460 million of senior unsecured convertible notes at 3% cash interest, maturing September 1, 2029, with a $11.00/share conversion price, used to refinance debt and eliminate covenants.
Source (primary)
Third Quarter Fiscal Year 2024 Earnings Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-10-16)Live source ↗
Quote: “$460 million 3% cash interest Semi-annually in arrears: March 1st and September 1st September 1, 2029”
How we checked this
Checked on October 17, 2026. The cited source supports every part of this claim.
The appendix term sheet gives the principal, rate, maturity and conversion price, and the 2024 snapshot says the offering refinanced debt and eliminated covenants.
Confirmed in the source:
- The company issued $460 million of senior unsecured convertible notes
- The notes carry 3% cash interest
- The notes mature September 1, 2029
- The notes have an $11.00 per share conversion price
- The note offering was used to refinance debt and eliminate covenants
What we did: Read our cached copy of IR page (investors.corescientific.com) (https://d1io3yog0oux5.cloudfront.net/_b76ddaa46c59e7a64138659274ff5f32/corescientific/db/1066/11130/pdf/Core%2BScientific%2BQ3%2B2024%2BEarnings%2BPresentation.pdf) in full (24,743 characters, retrieved October 16, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Third Quarter Fiscal Year 2024 Earnings Presentation
Quote: “$460 million 3% cash interest Semi-annually in arrears: March 1st and September 1st September 1, 2029”